Global Market Access Specialist - VIE Contract

at  Sanofi

GLOBAL MARKET ACCESS SPECIALIST - VIE CONTRACT

• Location: Bridgewater, United States of America
• Target start date: 01/04/2025
  iMove, the Sanofi VIE Program, is available to citizens of the European Economic Area (EU + Norway, Liechtenstein and Iceland) aged between 18 and 28.
  PLEASE NOTE that since this program is primarily an international development program, candidates cannot apply to a VIE assignment in their own country of citizenship.
  PLEASE NOTE that applications that are only submitted in French cannot be considered by our non-French speaking partners at Sanofi worldwide. Therefore, only applications that are submitted in English will be considered. Please make sure to apply with your personal email address.

SOFT AND TECHNICAL SKILLS:

• Good knowledge of PowerPoint & Microsoft Office.
• Excellent written, verbal and interpersonal communication skills, with strong presentation skills.
• Self-motivated and driven.
• Attention to detail, organised, structured and follow-up skills.
• Proven project management skills (“timeline tracking”, “leadership without authority” etc)
• Easily adaptable to a multicultural environment.
• Willingness to learn in a fast-paced professional environment.

Education:

• Master’s degree in science, Pharmacy, Business, Health Economics, Public Health, Policy/Government Affairs, Marketing or related.

Languages:

• Fluent English (written and verbal).

• Coordinate project management activities related payer interactions such as payer advisory boards, negotiation readiness workshops, including market access affiliate training events, etc.
• Coordinate market access launch excellence work streams including project planning, dashboards, trackers, and reports.
• Support the Rhinology/Gastroenterology leads as needed in the development of global market access strategy/plan and deliverables (payer value story, payer objection handler, and other internal projects) for assigned Dupilumab indications based on business needs.
• Support Dupixent MAx launch execution and operations.